These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 31338336)

  • 1. Editorial: Recent Progresses in Amebiasis.
    Debnath A; Rodriguez MA; Ankri S
    Front Cell Infect Microbiol; 2019; 9():247. PubMed ID: 31338336
    [No Abstract]   [Full Text] [Related]  

  • 2. The antiretroviral lectin cyanovirin-N targets well-known and novel targets on the surface of Entamoeba histolytica trophozoites.
    Carpentieri A; Ratner DM; Ghosh SK; Banerjee S; Bushkin GG; Cui J; Lubrano M; Steffen M; Costello CE; O'Keefe B; Robbins PW; Samuelson J
    Eukaryot Cell; 2010 Nov; 9(11):1661-8. PubMed ID: 20852023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of intestinal amebiasis: from molecules to disease.
    Espinosa-Cantellano M; Martínez-Palomo A
    Clin Microbiol Rev; 2000 Apr; 13(2):318-31. PubMed ID: 10756002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive amebiasis: an update on diagnosis and management.
    Salles JM; Salles MJ; Moraes LA; Silva MC
    Expert Rev Anti Infect Ther; 2007 Oct; 5(5):893-901. PubMed ID: 17914922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-Throughput Screening of
    Ehrenkaufer GM; Suresh S; Solow-Cordero D; Singh U
    Front Cell Infect Microbiol; 2018; 8():276. PubMed ID: 30175074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difficulties in the treatment of intestinal amoebiasis in mentally disabled individuals at a rehabilitation institution for the intellectually impaired in Japan.
    Fujishima T; Nishise S; Ichihara M; Kobayashi S; Takeuchi T
    Chemotherapy; 2010; 56(4):348-52. PubMed ID: 20720419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiamebic studies on 5-chloro-793-diethylaminopropyl-aminomethyl)-8-quinolinol in vitro and in experimentally infected animals.
    Thompson PE; Bayles A; McClay P; Meisenhelder JE
    J Parasitol; 1965 Oct; 51(5):817-22. PubMed ID: 4285520
    [No Abstract]   [Full Text] [Related]  

  • 8. Target identification and intervention strategies against amebiasis.
    Nagaraja S; Ankri S
    Drug Resist Updat; 2019 May; 44():1-14. PubMed ID: 31112766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Intestinal amebiasis. A diagnosis with many faces].
    Markwalder K
    Internist (Berl); 1984 Apr; 25(4):216-21. PubMed ID: 6327559
    [No Abstract]   [Full Text] [Related]  

  • 10. A new drug (MK-910) in the therapy of intestinal and hepatic amebiasis. First results of clinical trial.
    Chari MV; Gadiyar BN
    Am J Trop Med Hyg; 1970 Nov; 19(6):926-8. PubMed ID: 4321790
    [No Abstract]   [Full Text] [Related]  

  • 11. Entamoeba thiol-based redox metabolism: A potential target for drug development.
    Jeelani G; Nozaki T
    Mol Biochem Parasitol; 2016; 206(1-2):39-45. PubMed ID: 26775086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of duodenal Entamoeba histolytica.
    Feagins LA; Chan V; Spechler SJ
    Gastrointest Endosc; 2009 May; 69(6):1184-6. PubMed ID: 19410047
    [No Abstract]   [Full Text] [Related]  

  • 13. Bioactivity of Farnesyltransferase Inhibitors Against
    Probst A; Nguyen TN; El-Sakkary N; Skinner D; Suzuki BM; Buckner FS; Gelb MH; Caffrey CR; Debnath A
    Front Cell Infect Microbiol; 2019; 9():180. PubMed ID: 31192168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of paromomycin for treating amebiasis in Japan.
    Kikuchi T; Koga M; Shimizu S; Miura T; Maruyama H; Kimura M
    Parasitol Int; 2013 Dec; 62(6):497-501. PubMed ID: 23850836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of an Entamoeba histolytica high-mobility-group box protein induced during intestinal infection.
    Abhyankar MM; Hochreiter AE; Hershey J; Evans C; Zhang Y; Crasta O; Sobral BW; Mann BJ; Petri WA; Gilchrist CA
    Eukaryot Cell; 2008 Sep; 7(9):1565-72. PubMed ID: 18658254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and treatment of amebiasis].
    Prensa Med Argent; 1970 Sep; 57(30):1467-76. PubMed ID: 4320185
    [No Abstract]   [Full Text] [Related]  

  • 17. [Amoebic dysentery].
    Yoshikawa K; Sagara H
    Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):423-6. PubMed ID: 10201245
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative proteomic analysis of two Entamoeba histolytica strains with different virulence phenotypes identifies peroxiredoxin as an important component of amoebic virulence.
    Davis PH; Zhang X; Guo J; Townsend RR; Stanley SL
    Mol Microbiol; 2006 Sep; 61(6):1523-32. PubMed ID: 16968225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Invading intestinal amebiasis in infants (author's transl)].
    Atias A; Ruíz-Esquide F; Escobar E; Schilling E
    Rev Med Chil; 1977 Jul; 105(7):456-9. PubMed ID: 199929
    [No Abstract]   [Full Text] [Related]  

  • 20. The Brief Case: A Rare Case of Invasive Amebiasis Requiring Emergency Subtotal Colectomy in an HIV-Positive Man.
    Wingfield T; Ball R; Woolley SD; Campbell F; Heath RM; Beeching NJ; Turtle L
    J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 30049805
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.